ERGO — Entia Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Entia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 December 31st	2013 December 31st	C2014 December 31st	2015 December 31st	2016 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.013	0.037	0.099	0.024	0.076
Net Total Accounts Receivable
Net Total Receivables	0.066	0.015	0.244	0.007	0.008
Total Inventory
Prepaid Expenses
Total Current Assets	0.244	0.225	0.437	0.128	0.234
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.036	0.062	0.043	0.033	0.018
Net Intangible Assets
Other Long Term Assets
Total Assets	0.463	0.631	0.871	0.449	0.439
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	1.11	1.58	0.987	1.24	2.11
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	1.11	1.58	0.987	1.24	2.41
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.648	-0.95	-0.117	-0.791	-1.97
Total Liabilities & Shareholders' Equity	0.463	0.631	0.871	0.449	0.439
Total Common Shares Outstanding
Total Preferred Shares Outstanding